• Skip to main content
  • Skip to footer
Eco Friendly CBD OIL

Eco Friendly CBD OIL

The Best Eco Friendly CBD Oil

  • Home
  • CBD Health
  • Cannabis News
  • Contact

Cannabis News

Connecticut Governor Vows to Veto Senate’s Adult-Use Cannabis Bill

June 16, 2021 by CBD OIL

Social equity has been a pillar for adult-use cannabis passage among many state legislatures that have recently adopted public policy to end prohibition. But language surrounding social equity applications and funding may be the demise of legislation in Connecticut.

The Connecticut Senate passed an adult-use bill by a 19-12 vote during special session June 15, a week after the upper chamber passed the legislation with the same number of yeses during its regular season.

Threats of a House Republican filibuster on the final day before the Legislature adjourned June 9 sidelined the legislation, prompting Gov. Ned Lamont to call the special session.

RELATED: Clock is Ticking for Adult-Use Cannabis Bill in Connecticut 

While Lamont supports adult-use legalization—he proposed it during his February state budget request—the governor vowed to veto the new bill, Senate Bill 1201, over language involving social equity eligibility rules adopted through Amendment A in Tuesday’s special session.

Paul Mounds, the Democratic governor’s chief of staff, said in a statement that the current version of the bill “does not meet the goals laid out during negotiations when it comes to equity and ensuring the wrongs of the past are righted. To the contrary, this proposal opens the floodgates for tens of thousands of previously ineligible applicants to enter the adult-use cannabis industry.”

Specifically, the amendment would allow those with previous drug arrests or convictions a better chance to enter the state-legal cannabis industry through winning social equity licenses made available through the bill.

In his opening remarks Tuesday, Democratic Sen. Gary Winfield, who co-chairs the Joint Judiciary Committee, laid out the framework of Amendment A.

“[The amendment deals] with an issue that was in the definition of [a] social equity applicant, where some people believe that you might not allow for people who have found themselves in our prisons, for actions they had taken during the prohibition of cannabis, to participate,” he said. “It clarifies that. It is an amendment that I think helps to make this bill a better bill.”

In other words, individuals who have paid their debt to society through a prison term or other court orders, or those who have had their records expunged, would be eligible to receive a social equity license.

Among other revisions, the amendment also allows for community service in the place of a fine for those who are indigent; bans elected officials from participating in the cannabis industry laid out in the bill for two years after leaving the General Assembly; eliminates the study of home grows and instead moves forward with home grows (three mature and three immature plants); and requires tetrahydrocannabinol (THC) labels to include the content of products.

Republican Sen. John Kissel, who spoke for roughly 90 minutes in opposition of the underlying bill during last week’s regular-session debate, supported this week’s changes in Amendment A, which passed in a 26-4 vote. Notably, Kissel said he’s a proponent of the amendment’s provision to place a two-year restriction on state lawmakers from entering the industry following the time they leave office.

“From the 30,000-foot mark, I think a lot of the provisions in the amendment move the bill in a positive direction from my perspective, even though I don’t support the legalization of [adult-use cannabis],” Kissel said.

Connecticut Network | ct-n.com

Republican Sen. Dan Champagne talks about his opposition to an amendment included in the adult-use cannabis bill the Connecticut Senate passed in a special session June 15. 

Republican Sen. Dan Champagne, who voted against the amendment, said he didn’t support the social equity applicant language because he doesn’t think people with previous cannabis-related arrests or convictions should be given favorable opportunities over the rest of the state’s 3.6 million people to receive licenses to enter in the industry.

Champagne said he views “equitable” as fair and impartial.

“I’m looking at this as, you know, when arrests are made, arrests are made for people that do something wrong,” he said. “Whether people today say that it wasn’t viewed as something wrong, it doesn’t make a difference. At the time, this legislative body basically made laws and those laws were enforced, and people got arrested.

“We should never give somebody a leg up on a job. We should make sure we treat people as equals.”

According to the bill’s text, nearly half of the state’s licenses to cultivate and sell cannabis would be granted to social equity applicants (or those who reside in neighborhoods adversely impacted by the war on drugs). 

Social equity licensees would also receive a 50% discount on license fees for the first three years of renewals.

The bill sets aside a portion of the licenses for social equity “to deal with the fact that we have policy that has affected these communities in ways that I don’t think any of us want our communities to have ever been affected and allows for them to get into the program that we would have,” Winfield said “There are many people that, no matter what you do, who will have a greater chance in participating in this system than any of us. And particularly, communities of color that have been operated upon because of the way we’ve chosen to operate in this state for many years.

“And, so, I see this as a conversation on equity, where some people will say, ‘Well, you’re getting more than I’m getting.’ That’s not what the conversation is about. The conversation is about the fact that some things have happened, and you have to go back and deal with the fact that they’ve happened. And that doesn’t mean equal—it means equitable.”

After the amendment was passed, Champagne said he also opposed the portion of the main bill dealing with taxes generated from adult-use cannabis sales, from which 65% would go toward social equity, 25% to drug rehabilitation and 10% to the state’s general fund. A Social Equity Council would oversee appropriations for the 65% portion of the taxes, which Champagne said he had concerns with because only two of 15 appointments for that council would come from Republicans.

Instead, that money should be allocated through the budget process by the Legislature—from the general fund—and not an outside group, he said.

“I would consider this not bipartisan on the makeup of this committee,” Champagne said. “And they’re responsible for 65 percent of the income coming off the marijuana tax, which is millions of dollars.”

With S.B. 1201 passing the Senate, the House members are scheduled to take up the legislation during the second day of the special session, June 16.

Filed Under: Cannabis News

SC Labs Develops Comprehensive Hemp Testing Panel

June 16, 2021 by CBD OIL

SC Labs, a cannabis testing company with roots in Santa Cruz, California, announced this week that they have developed a comprehensive hemp testing panel that covers a number of contaminants on a national regulatory level. In the press release, the company says they aim to fill the void of national hemp testing requirements.

The hemp testing panel they have developed purportedly meets testing standards in states that require contaminant levels below a certain action limit. The SC Labs hemp testing panel could theoretically be used for regulatory compliance testing across the country, reaching action limits and analyte levels that meet the strictest state requirements.

The panel tests for pesticides, heavy metals, microbiology, mycotoxins, residual solvents and water activity. In the press release, the company says they have received ISO accreditation for the panel, although it’s not immediately clear to what standard it has been accredited.

Still, the test panel is one sign of progress in the long road to nationally harmonized testing standards. “As an industry, we’ve been advocating for national, standardized, and transparent testing regulations for years now,” says Jeff Gray, CEO of SC Labs. “The government has been slow to respond so we decided it was time to act. As an industry, we’ve been advocating for national, standardized, and transparent testing regulations for years now. The government has been slow to respond so we decided it was time to act.”

SC Labs is headquartered in Santa Cruz, but has licenses in California, Oregon, Texas and Colorado (pending). Their California and Oregon locations are both ISO 17025-accredited and conducting THC-containing cannabis testing, as well as hemp testing.

Filed Under: Cannabis News

New Perspectives on Navigating IRS Cannabis Tax Policies

June 16, 2021 by CBD OIL

It’s been a busy year for federal cannabis legislation. Will all the activity lead to legalization – or even incremental progress on changing federal law? 

Federal cannabis reform hasn’t passed into law, but it’s not for lack of trying. In 2021 alone, several high-profile cannabis bills have been proposed in both chambers of Congress, while others have been promised later this year.

Moving into the second half of 2021, let’s examine the most prominent federal cannabis bills, assess their current status, and with the help of industry experts, make some predictions about the future.

The Marijuana Opportunity Reinvestment and Expungement (MORE) Act

Introduced in the House by Rep. Jerry Nadler (D-NY) & other Democratic representatives

May 2021

The current flagship legislation for comprehensive cannabis legalization, the MORE Act was first introduced in the summer of 2019. It passed a full floor vote in December 2020, making history as the first bill to explicitly legalize cannabis to pass in Congress.

Since the bill’s inception, however, momentum has been slowed by a lack of bipartisan support – particularly related to the bill’s strong social equity provisions, which would devote federal grants to help communities hurt most by the War on Drugs. 

“In order to pass the Senate, you’re going to need to get 10 Republicans on board with a descheduling bill without alienating Democrats, and I think that can be pretty tricky,” said Morgan Fox, Director of Media Relations for the National Cannabis Industry Association in a phone interview. “Particularly since in the GOP, the main sticking point tends to be social equity.”

Last month, Rep. Nadler reintroduced the MORE Act, highlighting advancements in state-level cannabis reform in an accompanying statement: “Since I introduced the MORE Act last Congress, numerous states across the nation, including my home state of New York, have moved to legalize marijuana. Our federal laws must keep up with this pace,” said Nadler, who chairs the House Judiciary Committee.

The Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act

Introduced in the House by Reps. David Joyce (R-OH) and Don Young (R-AK)

May 2021

Perhaps recognizing the desire among their Republican party for simple legalization without any social justice provisions, two GOP representatives introduced a bill that would remove cannabis from the DEA’s Controlled Substances schedule, provide protection for cannabis-related financial services companies, and offer blanket protection for veterans to use medical cannabis in accordance with state laws. 

Reps. Joyce and Young, who are members of the bipartisan Congressional Cannabis Caucus, may have introduced the bill as an opening for House Republicans to support plain legalization without attaching their vote to the kind of progressive reform measures included in other legislation.

“One of the reasons the Joyce bill was introduced in the House was to see which Republicans are completely against legalization and which ones are okay with a simple, straightforward bill that only deschedules and doesn’t include any social justice or restorative issues,” said Fox.

Untitled Comprehensive Cannabis Reform

Upcoming in Senate by Senators Cory Booker (D-NY), Ron Wyden (D-OR) and Chuck Schumer (D-NY)

(Announced) February 2021

This piece of federal cannabis legislation is distinct from others in one important way: No one has seen it. From what the Senators have been saying about it for several months, the legislative package will focus on legalizing cannabis reform, while also striving to “right the wrongs of this failed war [on drugs] and end decades of harm inflicted on communities of color,” and “enact measures that will lift up people who were unfairly targeted in the War on Drugs.” Its promised social justice and equity measures have made it highly anticipated by the industry, but details are scant.

“Nobody to my knowledge outside of their offices has gotten a look at the actual language yet,” said Fox. “So far we’ve been hearing it’s going to be pretty heavy on restorative justice and social equity provisions…but again, we don’t know exactly what that looks like. So I think it’s going to be pretty important, once we see the details, to do a line-by-line with the MORE Act and see how they compare and contrast.”

Dasheeda Dawson, Cannabis Program Manager for the City of Portland and Chair of Cannabis Regulators of Color Coalition (CRCC), said it’s fair to expect the Senate legalization package to go even further than the MORE Act when it comes to restorative justice, given the history of the Senators involved.

“We expect MORE will be the baseline for the Schumer, Booker & Wyden efforts in the Senate,” said Dawson in an email to Cannabis Business Times and Cannabis Dispensary. “Much of the foundation of the MORE Act was built on Booker’s Marijuana Justice Act of 2017. If anything, because of the additional time and New York’s landmark legalization bill, I believe the Senate bill will be a slight step above the MORE Act as it pertains to restorative justice and equity.”  

The Secure and Fair Enforcement in (SAFE) Banking Act

Introduced in the House by Rep. Ed Perlmutter (D-CO)

March 2021 – passed April 2021 

The SAFE Banking Act is a more incremental reform step that would allow cannabis businesses access to the same kind of banking products available for other businesses, including credit and insurance. It also provides legal protection for ancillary businesses that provide service to the cannabis industry, such as contractors and packaging companies.

The bill has now passed a full floor vote in the House twice: once in September 2019, and once this past April, after its most recent introduction by Rep. Perlmutter. Now that even more Americans support full cannabis legalization, some in the industry hope the time is finally right to at least allow cannabis companies access to relatively basic business tools.

“SAFE Banking enjoys the support of the banking industry and many Republicans, so it could be seen as a fallback option should comprehensive legalization ultimately fail,” said Kris Krane, Founder of 4Front Ventures and President of Mission Dispensaries. 

But others believe that incremental progress could actually represent a step backwards for cannabis equity.

“On surface the SAFE Banking Act is a helpful band-aid for those already privileged to be participants in this developing industry,” said Dawson. “Passage of SAFE would be an incremental step that actually would further the gap in equity for this industry, even if it temporarily relieves small cannabis business[es] from the oppression of cash-only business management. There’s also risk that it will encourage much bigger industry players, like Amazon, to begin their money moves to position themselves for future domination.” 

In an early June blog post, Amazon announced it would no longer screen prospective hires for cannabis and its policy team would be “actively supporting” the MORE Act.

For now, the SAFE Banking Act awaits a hearing in the Senate after passing a floor vote in the House – just like the MORE Act.

The Hemp Access and Consumer Safety Act

Introduced in the Senate by Senators Rand Paul (R-KY), Ron Wyden (D-OR), and Jeff Merkley (D-OR)

May 2021

Like the SAFE Banking Act, the Hemp Access and Consumer Safety Act is a more incremental cannabis bill that would confirm the legal status of cannabidiol (CBD) and other hemp-derived supplements in foods and beverages. The bill is a companion to the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021, which was introduced in the House in February.

The Hemp Access act is designed to help bring clarity to a lucrative yet confusing industry: hemp and CBD. Right now, these products are sold in a gray area, since they’re not technically approved under federal law. Under the Farm Bill of 2018, The Food and Drug Administration (FDA) was supposed to create guidelines to regulate this prominent sector of the cannabis industry. To date, however, not much progress has been made outside of a few statements and official updates.

“The Hemp Access and Consumer Safety Act is a bill that only exists because the FDA has not done its job of regulating hemp-derived cannabinoids as an ingredient,” said Dawson. “I suspect this bill will be supported because it essentially compels the FDA to treat hemp-derived CBD specifically like a dietary supplement.”

“Theoretically it could move pretty easily, since it’s pretty narrowly-focused and is mandating something the FDA promised to do anyway and just hasn’t gotten around to yet,” added Fox when asked about the prospects of the bill in the Senate.

Despite all this activity, industry insiders are still pessimistic about federal cannabis legislation – particularly on a comprehensive scale.

“I think there’s definitely a chance of something passing this year but I don’t necessarily think that it’s going to be a comprehensive descheduling bill,” predicted Fox. 

“At this point, we don’t expect federal legalization to happen this year,” said Dawson. “There is still too large of a gap in cannabis competency at the federal level, across legislators and would-be regulators.”

 

Filed Under: Cannabis News

California Approves $100 Million in Grant Funding to Boost Cannabis Industry

June 16, 2021 by CBD OIL

It’s been a busy year for federal cannabis legislation. Will all the activity lead to legalization – or even incremental progress on changing federal law? 

Federal cannabis reform hasn’t passed into law, but it’s not for lack of trying. In 2021 alone, several high-profile cannabis bills have been proposed in both chambers of Congress, while others have been promised later this year.

Moving into the second half of 2021, let’s examine the most prominent federal cannabis bills, assess their current status, and with the help of industry experts, make some predictions about the future.

The Marijuana Opportunity Reinvestment and Expungement (MORE) Act

Introduced in the House by Rep. Jerry Nadler (D-NY) & other Democratic representatives

May 2021

The current flagship legislation for comprehensive cannabis legalization, the MORE Act was first introduced in the summer of 2019. It passed a full floor vote in December 2020, making history as the first bill to explicitly legalize cannabis to pass in Congress.

Since the bill’s inception, however, momentum has been slowed by a lack of bipartisan support – particularly related to the bill’s strong social equity provisions, which would devote federal grants to help communities hurt most by the War on Drugs. 

“In order to pass the Senate, you’re going to need to get 10 Republicans on board with a descheduling bill without alienating Democrats, and I think that can be pretty tricky,” said Morgan Fox, Director of Media Relations for the National Cannabis Industry Association in a phone interview. “Particularly since in the GOP, the main sticking point tends to be social equity.”

Last month, Rep. Nadler reintroduced the MORE Act, highlighting advancements in state-level cannabis reform in an accompanying statement: “Since I introduced the MORE Act last Congress, numerous states across the nation, including my home state of New York, have moved to legalize marijuana. Our federal laws must keep up with this pace,” said Nadler, who chairs the House Judiciary Committee.

The Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act

Introduced in the House by Reps. David Joyce (R-OH) and Don Young (R-AK)

May 2021

Perhaps recognizing the desire among their Republican party for simple legalization without any social justice provisions, two GOP representatives introduced a bill that would remove cannabis from the DEA’s Controlled Substances schedule, provide protection for cannabis-related financial services companies, and offer blanket protection for veterans to use medical cannabis in accordance with state laws. 

Reps. Joyce and Young, who are members of the bipartisan Congressional Cannabis Caucus, may have introduced the bill as an opening for House Republicans to support plain legalization without attaching their vote to the kind of progressive reform measures included in other legislation.

“One of the reasons the Joyce bill was introduced in the House was to see which Republicans are completely against legalization and which ones are okay with a simple, straightforward bill that only deschedules and doesn’t include any social justice or restorative issues,” said Fox.

Untitled Comprehensive Cannabis Reform

Upcoming in Senate by Senators Cory Booker (D-NY), Ron Wyden (D-OR) and Chuck Schumer (D-NY)

(Announced) February 2021

This piece of federal cannabis legislation is distinct from others in one important way: No one has seen it. From what the Senators have been saying about it for several months, the legislative package will focus on legalizing cannabis reform, while also striving to “right the wrongs of this failed war [on drugs] and end decades of harm inflicted on communities of color,” and “enact measures that will lift up people who were unfairly targeted in the War on Drugs.” Its promised social justice and equity measures have made it highly anticipated by the industry, but details are scant.

“Nobody to my knowledge outside of their offices has gotten a look at the actual language yet,” said Fox. “So far we’ve been hearing it’s going to be pretty heavy on restorative justice and social equity provisions…but again, we don’t know exactly what that looks like. So I think it’s going to be pretty important, once we see the details, to do a line-by-line with the MORE Act and see how they compare and contrast.”

Dasheeda Dawson, Cannabis Program Manager for the City of Portland and Chair of Cannabis Regulators of Color Coalition (CRCC), said it’s fair to expect the Senate legalization package to go even further than the MORE Act when it comes to restorative justice, given the history of the Senators involved.

“We expect MORE will be the baseline for the Schumer, Booker & Wyden efforts in the Senate,” said Dawson in an email to Cannabis Business Times and Cannabis Dispensary. “Much of the foundation of the MORE Act was built on Booker’s Marijuana Justice Act of 2017. If anything, because of the additional time and New York’s landmark legalization bill, I believe the Senate bill will be a slight step above the MORE Act as it pertains to restorative justice and equity.”  

The Secure and Fair Enforcement in (SAFE) Banking Act

Introduced in the House by Rep. Ed Perlmutter (D-CO)

March 2021 – passed April 2021 

The SAFE Banking Act is a more incremental reform step that would allow cannabis businesses access to the same kind of banking products available for other businesses, including credit and insurance. It also provides legal protection for ancillary businesses that provide service to the cannabis industry, such as contractors and packaging companies.

The bill has now passed a full floor vote in the House twice: once in September 2019, and once this past April, after its most recent introduction by Rep. Perlmutter. Now that even more Americans support full cannabis legalization, some in the industry hope the time is finally right to at least allow cannabis companies access to relatively basic business tools.

“SAFE Banking enjoys the support of the banking industry and many Republicans, so it could be seen as a fallback option should comprehensive legalization ultimately fail,” said Kris Krane, Founder of 4Front Ventures and President of Mission Dispensaries. 

But others believe that incremental progress could actually represent a step backwards for cannabis equity.

“On surface the SAFE Banking Act is a helpful band-aid for those already privileged to be participants in this developing industry,” said Dawson. “Passage of SAFE would be an incremental step that actually would further the gap in equity for this industry, even if it temporarily relieves small cannabis business[es] from the oppression of cash-only business management. There’s also risk that it will encourage much bigger industry players, like Amazon, to begin their money moves to position themselves for future domination.” 

In an early June blog post, Amazon announced it would no longer screen prospective hires for cannabis and its policy team would be “actively supporting” the MORE Act.

For now, the SAFE Banking Act awaits a hearing in the Senate after passing a floor vote in the House – just like the MORE Act.

The Hemp Access and Consumer Safety Act

Introduced in the Senate by Senators Rand Paul (R-KY), Ron Wyden (D-OR), and Jeff Merkley (D-OR)

May 2021

Like the SAFE Banking Act, the Hemp Access and Consumer Safety Act is a more incremental cannabis bill that would confirm the legal status of cannabidiol (CBD) and other hemp-derived supplements in foods and beverages. The bill is a companion to the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021, which was introduced in the House in February.

The Hemp Access act is designed to help bring clarity to a lucrative yet confusing industry: hemp and CBD. Right now, these products are sold in a gray area, since they’re not technically approved under federal law. Under the Farm Bill of 2018, The Food and Drug Administration (FDA) was supposed to create guidelines to regulate this prominent sector of the cannabis industry. To date, however, not much progress has been made outside of a few statements and official updates.

“The Hemp Access and Consumer Safety Act is a bill that only exists because the FDA has not done its job of regulating hemp-derived cannabinoids as an ingredient,” said Dawson. “I suspect this bill will be supported because it essentially compels the FDA to treat hemp-derived CBD specifically like a dietary supplement.”

“Theoretically it could move pretty easily, since it’s pretty narrowly-focused and is mandating something the FDA promised to do anyway and just hasn’t gotten around to yet,” added Fox when asked about the prospects of the bill in the Senate.

Despite all this activity, industry insiders are still pessimistic about federal cannabis legislation – particularly on a comprehensive scale.

“I think there’s definitely a chance of something passing this year but I don’t necessarily think that it’s going to be a comprehensive descheduling bill,” predicted Fox. 

“At this point, we don’t expect federal legalization to happen this year,” said Dawson. “There is still too large of a gap in cannabis competency at the federal level, across legislators and would-be regulators.”

 

Filed Under: Cannabis News

Eteros Launches Mobius M9 Sorter, Boasting Industry-Leading Technology to Speed Sorting and Precise Sizing

June 15, 2021 by CBD OIL

<![CDATA[

LAS VEGAS, June 10, 2021 – PRESS RELEASE – Canadian-based Eteros Technologies, owner of Mobius Trimmer, a brand of high-end cannabis and hemp processing equipment, revealed its latest technological achievement, the M9 Sorter, featuring an industry-leading combination of features to ensure high-speed sorting and precise product sizing. The launch was announced at the company’s “Demo in the Desert” event held at the recently opened Eteros Las Vegas facility, which will serve as the final assembly plant for the new product in the U.S. cannabis market.

“Cannabis cultivators and processors are always engaged in a constant battle to increase yields, reduce loss and ensure high quality is maintained during the trimming process,” Mobius Trimmer CEO Aaron McKellar said. “When sorting can handle more product in less time while increasing accuracy in sizing, a large part of the battle is won. The M9 Sorter is designed with this goal in mind and incorporates a long list of features to get there.”

Features of the M9 include:

  • An industry-leading nine sorting belts
  • An industry-leading 78-inch sorting zone for high-speed and precise sizing of product
  • A longer sorting table that leads to more accurate results
  • Every grading slot is longer, creating more opportunity for an accurate sort, and each grading partition is fully adjustable
  • All stainless-steel construction
  • Sanitary construction for GMP workflows
  • Adjustable infeed hopper: tool-free adjustment and removal for feeding or conveyor infeed
  • Reversible table for operation in either left or right outfeed configuration
  • Easy access for cleaning with safety interlocked end panels and rear door
  • 7-inch HMI color controller
  • Accurately grades up to 200 kilograms per hour

As with all Mobius products, the Mobius M9 features quick and tool-free removal of all belts and rollers for easy and safe cleaning. The new product announcement comes during a period of strong growth for Eteros, following the acquisition of California-based Triminator, a pioneer in harvesting equipment for professional growers of cannabis and hemp, and the opening of the company’s Las Vegas location earlier this year.

“We are so encouraged by the reception we have received in Las Vegas since opening our facility earlier this year,” McKellar said. “The ability to serve U.S. customers from our new home base in the desert is a dream come true. We look forward to the opportunity to serve more of the U.S. community.”

The Mobius and Triminator product lines combine to form the world’s largest manufacturer of cannabis and hemp harvesting and processing equipment. Eteros Technologies, parent company of the Mobius line, plans to retain Triminator employees and leadership, and company officials said both brands will continue to operate independently. Working in synergy, each will marshal greater engineering, sales, training and support resources to offer customers the most comprehensive suite of processing solutions on the market. The acquisition also means that the full Canadian designed-and-built Mobius line and full U.S.-built Triminator product line will be stocked and available across North America.

]]>

Filed Under: Cannabis News

Virginia Tech Maintains Cannabis Prohibition on Campus

June 14, 2021 by CBD OIL

It’s been a busy year for federal cannabis legislation. Will all the activity lead to legalization – or even incremental progress on changing federal law? 

Federal cannabis reform hasn’t passed into law, but it’s not for lack of trying. In 2021 alone, several high-profile cannabis bills have been proposed in both chambers of Congress, while others have been promised later this year.

Moving into the second half of 2021, let’s examine the most prominent federal cannabis bills, assess their current status, and with the help of industry experts, make some predictions about the future.

The Marijuana Opportunity Reinvestment and Expungement (MORE) Act

Introduced in the House by Rep. Jerry Nadler (D-NY) & other Democratic representatives

May 2021

The current flagship legislation for comprehensive cannabis legalization, the MORE Act was first introduced in the summer of 2019. It passed a full floor vote in December 2020, making history as the first bill to explicitly legalize cannabis to pass in Congress.

Since the bill’s inception, however, momentum has been slowed by a lack of bipartisan support – particularly related to the bill’s strong social equity provisions, which would devote federal grants to help communities hurt most by the War on Drugs. 

“In order to pass the Senate, you’re going to need to get 10 Republicans on board with a descheduling bill without alienating Democrats, and I think that can be pretty tricky,” said Morgan Fox, Director of Media Relations for the National Cannabis Industry Association in a phone interview. “Particularly since in the GOP, the main sticking point tends to be social equity.”

Last month, Rep. Nadler reintroduced the MORE Act, highlighting advancements in state-level cannabis reform in an accompanying statement: “Since I introduced the MORE Act last Congress, numerous states across the nation, including my home state of New York, have moved to legalize marijuana. Our federal laws must keep up with this pace,” said Nadler, who chairs the House Judiciary Committee.

The Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act

Introduced in the House by Reps. David Joyce (R-OH) and Don Young (R-AK)

May 2021

Perhaps recognizing the desire among their Republican party for simple legalization without any social justice provisions, two GOP representatives introduced a bill that would remove cannabis from the DEA’s Controlled Substances schedule, provide protection for cannabis-related financial services companies, and offer blanket protection for veterans to use medical cannabis in accordance with state laws. 

Reps. Joyce and Young, who are members of the bipartisan Congressional Cannabis Caucus, may have introduced the bill as an opening for House Republicans to support plain legalization without attaching their vote to the kind of progressive reform measures included in other legislation.

“One of the reasons the Joyce bill was introduced in the House was to see which Republicans are completely against legalization and which ones are okay with a simple, straightforward bill that only deschedules and doesn’t include any social justice or restorative issues,” said Fox.

Untitled Comprehensive Cannabis Reform

Upcoming in Senate by Senators Cory Booker (D-NY), Ron Wyden (D-OR) and Chuck Schumer (D-NY)

(Announced) February 2021

This piece of federal cannabis legislation is distinct from others in one important way: No one has seen it. From what the Senators have been saying about it for several months, the legislative package will focus on legalizing cannabis reform, while also striving to “right the wrongs of this failed war [on drugs] and end decades of harm inflicted on communities of color,” and “enact measures that will lift up people who were unfairly targeted in the War on Drugs.” Its promised social justice and equity measures have made it highly anticipated by the industry, but details are scant.

“Nobody to my knowledge outside of their offices has gotten a look at the actual language yet,” said Fox. “So far we’ve been hearing it’s going to be pretty heavy on restorative justice and social equity provisions…but again, we don’t know exactly what that looks like. So I think it’s going to be pretty important, once we see the details, to do a line-by-line with the MORE Act and see how they compare and contrast.”

Dasheeda Dawson, Cannabis Program Manager for the City of Portland and Chair of Cannabis Regulators of Color Coalition (CRCC), said it’s fair to expect the Senate legalization package to go even further than the MORE Act when it comes to restorative justice, given the history of the Senators involved.

“We expect MORE will be the baseline for the Schumer, Booker & Wyden efforts in the Senate,” said Dawson in an email to Cannabis Business Times and Cannabis Dispensary. “Much of the foundation of the MORE Act was built on Booker’s Marijuana Justice Act of 2017. If anything, because of the additional time and New York’s landmark legalization bill, I believe the Senate bill will be a slight step above the MORE Act as it pertains to restorative justice and equity.”  

The Secure and Fair Enforcement in (SAFE) Banking Act

Introduced in the House by Rep. Ed Perlmutter (D-CO)

March 2021 – passed April 2021 

The SAFE Banking Act is a more incremental reform step that would allow cannabis businesses access to the same kind of banking products available for other businesses, including credit and insurance. It also provides legal protection for ancillary businesses that provide service to the cannabis industry, such as contractors and packaging companies.

The bill has now passed a full floor vote in the House twice: once in September 2019, and once this past April, after its most recent introduction by Rep. Perlmutter. Now that even more Americans support full cannabis legalization, some in the industry hope the time is finally right to at least allow cannabis companies access to relatively basic business tools.

“SAFE Banking enjoys the support of the banking industry and many Republicans, so it could be seen as a fallback option should comprehensive legalization ultimately fail,” said Kris Krane, Founder of 4Front Ventures and President of Mission Dispensaries. 

But others believe that incremental progress could actually represent a step backwards for cannabis equity.

“On surface the SAFE Banking Act is a helpful band-aid for those already privileged to be participants in this developing industry,” said Dawson. “Passage of SAFE would be an incremental step that actually would further the gap in equity for this industry, even if it temporarily relieves small cannabis business[es] from the oppression of cash-only business management. There’s also risk that it will encourage much bigger industry players, like Amazon, to begin their money moves to position themselves for future domination.” 

In an early June blog post, Amazon announced it would no longer screen prospective hires for cannabis and its policy team would be “actively supporting” the MORE Act.

For now, the SAFE Banking Act awaits a hearing in the Senate after passing a floor vote in the House – just like the MORE Act.

The Hemp Access and Consumer Safety Act

Introduced in the Senate by Senators Rand Paul (R-KY), Ron Wyden (D-OR), and Jeff Merkley (D-OR)

May 2021

Like the SAFE Banking Act, the Hemp Access and Consumer Safety Act is a more incremental cannabis bill that would confirm the legal status of cannabidiol (CBD) and other hemp-derived supplements in foods and beverages. The bill is a companion to the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021, which was introduced in the House in February.

The Hemp Access act is designed to help bring clarity to a lucrative yet confusing industry: hemp and CBD. Right now, these products are sold in a gray area, since they’re not technically approved under federal law. Under the Farm Bill of 2018, The Food and Drug Administration (FDA) was supposed to create guidelines to regulate this prominent sector of the cannabis industry. To date, however, not much progress has been made outside of a few statements and official updates.

“The Hemp Access and Consumer Safety Act is a bill that only exists because the FDA has not done its job of regulating hemp-derived cannabinoids as an ingredient,” said Dawson. “I suspect this bill will be supported because it essentially compels the FDA to treat hemp-derived CBD specifically like a dietary supplement.”

“Theoretically it could move pretty easily, since it’s pretty narrowly-focused and is mandating something the FDA promised to do anyway and just hasn’t gotten around to yet,” added Fox when asked about the prospects of the bill in the Senate.

Despite all this activity, industry insiders are still pessimistic about federal cannabis legislation – particularly on a comprehensive scale.

“I think there’s definitely a chance of something passing this year but I don’t necessarily think that it’s going to be a comprehensive descheduling bill,” predicted Fox. 

“At this point, we don’t expect federal legalization to happen this year,” said Dawson. “There is still too large of a gap in cannabis competency at the federal level, across legislators and would-be regulators.”

 

Filed Under: Cannabis News

Federal Cannabis Legislation Roundup: Summer 2021

June 14, 2021 by CBD OIL

It’s been a busy year for federal cannabis legislation. Will all the activity lead to legalization – or even incremental progress on changing federal law? 

Federal cannabis reform hasn’t passed into law, but it’s not for lack of trying. In 2021 alone, several high-profile cannabis bills have been proposed in both chambers of Congress, while others have been promised later this year.

Moving into the second half of 2021, let’s examine the most prominent federal cannabis bills, assess their current status, and with the help of industry experts, make some predictions about the future.

The Marijuana Opportunity Reinvestment and Expungement (MORE) Act

Introduced in the House by Rep. Jerry Nadler (D-NY) & other Democratic representatives

May 2021

The current flagship legislation for comprehensive cannabis legalization, the MORE Act was first introduced in the summer of 2019. It passed a full floor vote in December 2020, making history as the first bill to explicitly legalize cannabis to pass in Congress.

Since the bill’s inception, however, momentum has been slowed by a lack of bipartisan support – particularly related to the bill’s strong social equity provisions, which would devote federal grants to help communities hurt most by the War on Drugs. 

“In order to pass the Senate, you’re going to need to get 10 Republicans on board with a descheduling bill without alienating Democrats, and I think that can be pretty tricky,” said Morgan Fox, Director of Media Relations for the National Cannabis Industry Association in a phone interview. “Particularly since in the GOP, the main sticking point tends to be social equity.”

Last month, Rep. Nadler reintroduced the MORE Act, highlighting advancements in state-level cannabis reform in an accompanying statement: “Since I introduced the MORE Act last Congress, numerous states across the nation, including my home state of New York, have moved to legalize marijuana. Our federal laws must keep up with this pace,” said Nadler, who chairs the House Judiciary Committee.

The Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act

Introduced in the House by Reps. David Joyce (R-OH) and Don Young (R-AK)

May 2021

Perhaps recognizing the desire among their Republican party for simple legalization without any social justice provisions, two GOP representatives introduced a bill that would remove cannabis from the DEA’s Controlled Substances schedule, provide protection for cannabis-related financial services companies, and offer blanket protection for veterans to use medical cannabis in accordance with state laws. 

Reps. Joyce and Young, who are members of the bipartisan Congressional Cannabis Caucus, may have introduced the bill as an opening for House Republicans to support plain legalization without attaching their vote to the kind of progressive reform measures included in other legislation.

“One of the reasons the Joyce bill was introduced in the House was to see which Republicans are completely against legalization and which ones are okay with a simple, straightforward bill that only deschedules and doesn’t include any social justice or restorative issues,” said Fox.

Untitled Comprehensive Cannabis Reform

Upcoming in Senate by Senators Cory Booker (D-NY), Ron Wyden (D-OR) and Chuck Schumer (D-NY)

(Announced) February 2021

This piece of federal cannabis legislation is distinct from others in one important way: No one has seen it. From what the Senators have been saying about it for several months, the legislative package will focus on legalizing cannabis reform, while also striving to “right the wrongs of this failed war [on drugs] and end decades of harm inflicted on communities of color,” and “enact measures that will lift up people who were unfairly targeted in the War on Drugs.” Its promised social justice and equity measures have made it highly anticipated by the industry, but details are scant.

“Nobody to my knowledge outside of their offices has gotten a look at the actual language yet,” said Fox. “So far we’ve been hearing it’s going to be pretty heavy on restorative justice and social equity provisions…but again, we don’t know exactly what that looks like. So I think it’s going to be pretty important, once we see the details, to do a line-by-line with the MORE Act and see how they compare and contrast.”

Dasheeda Dawson, Cannabis Program Manager for the City of Portland and Chair of Cannabis Regulators of Color Coalition (CRCC), said it’s fair to expect the Senate legalization package to go even further than the MORE Act when it comes to restorative justice, given the history of the Senators involved.

“We expect MORE will be the baseline for the Schumer, Booker & Wyden efforts in the Senate,” said Dawson in an email to Cannabis Business Times and Cannabis Dispensary. “Much of the foundation of the MORE Act was built on Booker’s Marijuana Justice Act of 2017. If anything, because of the additional time and New York’s landmark legalization bill, I believe the Senate bill will be a slight step above the MORE Act as it pertains to restorative justice and equity.”  

The Secure and Fair Enforcement in (SAFE) Banking Act

Introduced in the House by Rep. Ed Perlmutter (D-CO)

March 2021 – passed April 2021 

The SAFE Banking Act is a more incremental reform step that would allow cannabis businesses access to the same kind of banking products available for other businesses, including credit and insurance. It also provides legal protection for ancillary businesses that provide service to the cannabis industry, such as contractors and packaging companies.

The bill has now passed a full floor vote in the House twice: once in September 2019, and once this past April, after its most recent introduction by Rep. Perlmutter. Now that even more Americans support full cannabis legalization, some in the industry hope the time is finally right to at least allow cannabis companies access to relatively basic business tools.

“SAFE Banking enjoys the support of the banking industry and many Republicans, so it could be seen as a fallback option should comprehensive legalization ultimately fail,” said Kris Krane, Founder of 4Front Ventures and President of Mission Dispensaries. 

But others believe that incremental progress could actually represent a step backwards for cannabis equity.

“On surface the SAFE Banking Act is a helpful band-aid for those already privileged to be participants in this developing industry,” said Dawson. “Passage of SAFE would be an incremental step that actually would further the gap in equity for this industry, even if it temporarily relieves small cannabis business[es] from the oppression of cash-only business management. There’s also risk that it will encourage much bigger industry players, like Amazon, to begin their money moves to position themselves for future domination.” 

In an early June blog post, Amazon announced it would no longer screen prospective hires for cannabis and its policy team would be “actively supporting” the MORE Act.

For now, the SAFE Banking Act awaits a hearing in the Senate after passing a floor vote in the House – just like the MORE Act.

The Hemp Access and Consumer Safety Act

Introduced in the Senate by Senators Rand Paul (R-KY), Ron Wyden (D-OR), and Jeff Merkley (D-OR)

May 2021

Like the SAFE Banking Act, the Hemp Access and Consumer Safety Act is a more incremental cannabis bill that would confirm the legal status of cannabidiol (CBD) and other hemp-derived supplements in foods and beverages. The bill is a companion to the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021, which was introduced in the House in February.

The Hemp Access act is designed to help bring clarity to a lucrative yet confusing industry: hemp and CBD. Right now, these products are sold in a gray area, since they’re not technically approved under federal law. Under the Farm Bill of 2018, The Food and Drug Administration (FDA) was supposed to create guidelines to regulate this prominent sector of the cannabis industry. To date, however, not much progress has been made outside of a few statements and official updates.

“The Hemp Access and Consumer Safety Act is a bill that only exists because the FDA has not done its job of regulating hemp-derived cannabinoids as an ingredient,” said Dawson. “I suspect this bill will be supported because it essentially compels the FDA to treat hemp-derived CBD specifically like a dietary supplement.”

“Theoretically it could move pretty easily, since it’s pretty narrowly-focused and is mandating something the FDA promised to do anyway and just hasn’t gotten around to yet,” added Fox when asked about the prospects of the bill in the Senate.

Despite all this activity, industry insiders are still pessimistic about federal cannabis legislation – particularly on a comprehensive scale.

“I think there’s definitely a chance of something passing this year but I don’t necessarily think that it’s going to be a comprehensive descheduling bill,” predicted Fox. 

“At this point, we don’t expect federal legalization to happen this year,” said Dawson. “There is still too large of a gap in cannabis competency at the federal level, across legislators and would-be regulators.”

 

Filed Under: Cannabis News

Connecticut Makes Headway on Cannabis Legalization (Sort Of): Week in Review

June 12, 2021 by CBD OIL

By now, many in the industry are aware of the recent craze surrounding delta-8 tetrahydrocannabinol (THC), a natural component of cannabis that has burst into popularity over the past several months.

And it seems as soon as the industry has gained a solid understanding of delta-8, another THC compound has come into the spotlight: delta-10 THC. 

Similar to delta-8, delta-10 is a minor cannabinoid that exists in trace amounts in hemp and cannabis, according to ACS Laboratory, a cannabis, hemp and cannabidiol (CBD) testing laboratory in Florida.

As previously reported by Hemp Grower, delta-8 is said to have a relaxing effect and produces some psychotropic effects that are believed to be less potent than delta-9.

Roger Brown, the president and founder of ACS Laboratory, describes the effects of delta-10 to be the opposite of delta-8, based on his personal experience.

“For myself, I don’t utilize or smoke marijuana, but I tried delta-8 and delta-10 products that we tested as an experiment, and for me, delta-10 had no psychoactive effects; it was more like a mood enhancer,” he says.

Erik Paulson, senior analyst at Infinite Chemical Analysis Labs, an analytical cannabis and CBD testing lab with locations in California and Michigan, says he’s heard consumers compare delta-10’s effects to sativa cannabis varieties, which are traditionally known for being energizing and uplifting, and delta-8 effects to indica varieties, which are associated with relaxation.

However, Paulson says he’s unsure if there’s any scientific evidence behind that, adding,  “It could just be that the higher psychoactivity of delta-8 is causing more of a pronounced sedative effect compared to delta-10.”

At this point, Paulson and Brown both say there is some published research on delta-10, though it is minimal.

A pigeon study conducted in the 1980s by Raphael Mechoulam, a cannabis research pioneer, studied the effects of delta-10 compared to delta-9 on pigeons. The study found that delta-10 may have some psychoactive effects, but the effects are much less potent than delta-9.

However, “there’s not as much known about delta-10 in terms of the psychoactivity and its effects on the human body,” Paulson says.

Where it Comes From

Like delta-8, delta-10 can be converted in a laboratory from delta-9 or CBD, Paulson says.

Delta-10 is typically produced more predominantly through extraction or converted from delta-9 through isomerization, he says. Transforming delta-9 to delta-10 (or delta-8) is possible because they have the same chemical compounds, just different structures.

According to Extraction Magazine, extractors would waste a significant amount of time and plant material trying to extract delta-10 from natural varieties, so it is more likely produced via isomerization. Delta-10 appears in such small amounts that laboratories often misidentify the compound for [cannabichromene] CBC or [cannabicyclol] CBL using standard high-performance liquid chromatography (HPLC) methods.

“You can create any delta you want—delta-8, delta-9, or delta-10—by chemically altering CBD isolate or CBD crude,” David Reckles, president of Private Label Hemp Lab, a hemp testing and manufacturing lab in Florida, told ACS Laboratory. “If you’re using crude CBD, you’ll generally create the reaction through carbon and vitamin C derivatives. If you’re using an isolate, you’ll incorporate solvents and acids.”

RELATED: Understanding Delta-8-THC: Where Does It Come From?

Delta-10 vs. Delta-8 and Delta-9: Chemical Differences

Delta-10 is an isomer of delta-9, Brown says.

Paulson says when one begins to isolate delta-9 or, more commonly, convert THC to CBD, they’ll start to discover the additional isomers (or different classifications of THC).

“Really, all THC isomers chemically have the same basic structure,” he says. “It’s just the placement of one bond that differs between the different isomers.”

For example, as previously reported by Hemp Grower, “delta-8 has a double bond on the 8th carbon chain, and delta-9 has a double bond on the 9th carbon chain.”

Delta-10 follows the same pattern and has a double bond on the 10th carbon chain. And while this seems like a “small distinction, it’s enough to produce slightly different cognitive and physical effects,” Hemp Grower previously reported.

Brown says that a significant difference is delta-8 can essentially only produce one compound, whereas delta-10 can produce up to six different isomers (variations of the same compound).

“What we call delta-10 is really a mixture of two different types of compounds, and then within that, they might have different configurations,” Paulson says. “So, there’s just a lot of different compounds, and that’s one of the reasons why it’s so challenging to quantify accurately. So, in terms of psychoactivity, instead of having to test one compound, you have to test six.” 

Legal Status

According to ACS Laboratory, “Delta-10 THC derived from cannabis is [federally] illegal because marijuana is a schedule 1 controlled substance. However, delta-10 derived from hemp extract exists in a legal gray zone.”

And Brown agrees, arguing that the Agriculture Improvement Act of 2018 (the 2018 Farm Bill) is very “specific to delta-9,” and if a delta-8 or delta-10 product derived from hemp contains less than 0.3% total THC (defined as delta-9 THC plus tetrahydrocannabinolic acid (THCA), its acidic version), then it’s considered “legal.”

The Drug Enforcement Administration’s (DEA) response to the 2018 Farm Bill is: “All synthetically derived tetrahydrocannabinols remain schedule 1 controlled substances.”

“So, in our mind, all tetrahydrocannabinols cannabinoids are considered federally illegal,” Paulson says. “We’re not placing a judgment on that, whether it’s right to do that or not. I just think there hasn’t been a lot of legal challenges to these laws and to that point, people keep on producing delta-8 and delta-10 products….”

More than 12 states have already begun to implement delta-8 bans, while very few states, including New York, Colorado and Alabama, have started to crack down on delta-10.

And Paulson says while delta-10 may currently be “flying under the radar,” he thinks it’s only a “matter of time” before there’s increased regulation.

Filed Under: Cannabis News

Surna Cultivation Technologies Introduces High Efficiency EcoChill Heat Recovery Chiller

June 10, 2021 by CBD OIL

By now, many in the industry are aware of the recent craze surrounding delta-8 tetrahydrocannabinol (THC), a natural component of cannabis that has burst into popularity over the past several months.

And it seems as soon as the industry has gained a solid understanding of delta-8, another THC compound has come into the spotlight: delta-10 THC. 

Similar to delta-8, delta-10 is a minor cannabinoid that exists in trace amounts in hemp and cannabis, according to ACS Laboratory, a cannabis, hemp and cannabidiol (CBD) testing laboratory in Florida.

As previously reported by Hemp Grower, delta-8 is said to have a relaxing effect and produces some psychotropic effects that are believed to be less potent than delta-9.

Roger Brown, the president and founder of ACS Laboratory, describes the effects of delta-10 to be the opposite of delta-8, based on his personal experience.

“For myself, I don’t utilize or smoke marijuana, but I tried delta-8 and delta-10 products that we tested as an experiment, and for me, delta-10 had no psychoactive effects; it was more like a mood enhancer,” he says.

Erik Paulson, senior analyst at Infinite Chemical Analysis Labs, an analytical cannabis and CBD testing lab with locations in California and Michigan, says he’s heard consumers compare delta-10’s effects to sativa cannabis varieties, which are traditionally known for being energizing and uplifting, and delta-8 effects to indica varieties, which are associated with relaxation.

However, Paulson says he’s unsure if there’s any scientific evidence behind that, adding,  “It could just be that the higher psychoactivity of delta-8 is causing more of a pronounced sedative effect compared to delta-10.”

At this point, Paulson and Brown both say there is some published research on delta-10, though it is minimal.

A pigeon study conducted in the 1980s by Ralph Micheolam, a cannabis research pioneer, studied the effects of delta-10 compared to delta-9 on pigeons. The study found that delta-10 may have some psychoactive effects, but the effects are much less potent than delta-9.

However, “there’s not as much known about delta-10 in terms of the psychoactivity and its effects on the human body,” Paulson says.

Where it Comes From

Like delta-8, delta-10 can be converted in a laboratory from delta-9 or CBD, Paulson says.

Delta-10 is typically produced more predominantly through extraction or converted from delta-9 through isomerization, he says. Transforming delta-9 to delta-10 (or delta-8) is possible because they have the same chemical compounds, just different structures.

According to Extraction Magazine, extractors would waste a significant amount of time and plant material trying to extract delta-10 from natural strains, so it is more likely produced via isomerization. Delta-10 appears in such small amounts that laboratories often misidentify the compound for [cannabichromene] CBC or [cannabicyclol] CBL using standard high-performance liquid chromatography (HPLC) methods.

“You can create any delta you want—delta-8, delta-9, or delta-10—by chemically altering CBD isolate or CBD crude,” David Reckles, president of Private Label Hemp Lab, a hemp testing and manufacturing lab in Florida, told ACS Laboratory. “If you’re using crude CBD, you’ll generally create the reaction through carbon and vitamin C derivatives. If you’re using an isolate, you’ll incorporate solvents and acids.”

RELATED: Understanding Delta-8-THC: Where Does It Come From?

Delta-10 vs. Delta-8 and Delta-9: Chemical Differences

Delta-10 is an isomer of delta-9, Brown says.

Paulson says when one begins to isolate delta-9 or, more commonly, convert THC to CBD, they’ll start to discover the additional isomers (or different classifications of THC).

“Really, all THC isomers chemically have the same basic structure,” he says. “It’s just the placement of one bond that differs between the different isomers.”

For example, as previously reported by Hemp Grower, “delta-8 has a double bond on the 8th carbon chain, and delta-9 has a double bond on the 9th carbon chain.”

Delta-10 follows the same pattern and has a double bond on the 10th carbon chain. And while this seems like a “small distinction, it’s enough to produce slightly different cognitive and physical effects,” Hemp Grower previously reported.

Brown says that a significant difference is delta-8 can essentially only produce one compound, whereas delta-10 can produce up to six different isomers (variations of the same compound).

“What we call delta-10 is really a mixture of two different types of compounds, and then within that, they might have different configurations,” Paulson says. “So, there’s just a lot of different compounds, and that’s one of the reasons why it’s so challenging to quantify accurately. So, in terms of psychoactivity, instead of having to test one compound, you have to test six.” 

Legal Status

According to ACS Laboratory, “Delta-10 THC derived from cannabis is [federally] illegal because marijuana is a schedule 1 controlled substance. However, delta-10 derived from hemp extract exists in a legal gray zone.”

And Brown agrees, arguing that the Agriculture Improvement Act of 2018 (the 2018 Farm Bill) is very “specific to delta-9,” and if a delta-8 or delta-10 product derived from hemp contains less than 0.3% total THC (defined as delta-9 THC plus tetrahydrocannabinolic acid (THCA), its acidic version), then it’s considered “legal.”

The Drug Enforcement Administration’s (DEA) response to the 2018 Farm Bill is: “All synthetically derived tetrahydrocannabinols remain schedule 1 controlled substances.”

“So, in our mind, all tetrahydrocannabinols cannabinoids are considered federally illegal,” Paulson says. “We’re not placing a judgment on that, whether it’s right to do that or not. I just think there hasn’t been a lot of legal challenges to these laws and to that point, people keep on producing delta-8 and delta-10 products….”

More than 12 states have already begun to implement delta-8 bans, while very few states, including New York, Colorado and Alabama, have started to crack down on delta-10.

And Paulson says while delta-10 may currently be “flying under the radar,” he thinks it’s only a “matter of time” before there’s increased regulation.

Filed Under: Cannabis News

Law Enforcement Action Partnership Joins Cannabis Freedom Alliance Steering Committee

June 10, 2021 by CBD OIL

By now, many in the industry are aware of the recent craze surrounding delta-8 tetrahydrocannabinol (THC), a natural component of cannabis that has burst into popularity over the past several months.

And it seems as soon as the industry has gained a solid understanding of delta-8, another THC compound has come into the spotlight: delta-10 THC. 

Similar to delta-8, delta-10 is a minor cannabinoid that exists in trace amounts in hemp and cannabis, according to ACS Laboratory, a cannabis, hemp and cannabidiol (CBD) testing laboratory in Florida.

As previously reported by Hemp Grower, delta-8 is said to have a relaxing effect and produces some psychotropic effects that are believed to be less potent than delta-9.

Roger Brown, the president and founder of ACS Laboratory, describes the effects of delta-10 to be the opposite of delta-8, based on his personal experience.

“For myself, I don’t utilize or smoke marijuana, but I tried delta-8 and delta-10 products that we tested as an experiment, and for me, delta-10 had no psychoactive effects; it was more like a mood enhancer,” he says.

Erik Paulson, senior analyst at Infinite Chemical Analysis Labs, an analytical cannabis and CBD testing lab with locations in California and Michigan, says he’s heard consumers compare delta-10’s effects to sativa cannabis varieties, which are traditionally known for being energizing and uplifting, and delta-8 effects to indica varieties, which are associated with relaxation.

However, Paulson says he’s unsure if there’s any scientific evidence behind that, adding,  “It could just be that the higher psychoactivity of delta-8 is causing more of a pronounced sedative effect compared to delta-10.”

At this point, Paulson and Brown both say there is some published research on delta-10, though it is minimal.

A pigeon study conducted in the 1980s by Ralph Micheolam, a cannabis research pioneer, studied the effects of delta-10 compared to delta-9 on pigeons. The study found that delta-10 may have some psychoactive effects, but the effects are much less potent than delta-9.

However, “there’s not as much known about delta-10 in terms of the psychoactivity and its effects on the human body,” Paulson says.

Where it Comes From

Like delta-8, delta-10 can be converted in a laboratory from delta-9 or CBD, Paulson says.

Delta-10 is typically produced more predominantly through extraction or converted from delta-9 through isomerization, he says. Transforming delta-9 to delta-10 (or delta-8) is possible because they have the same chemical compounds, just different structures.

According to Extraction Magazine, extractors would waste a significant amount of time and plant material trying to extract delta-10 from natural strains, so it is more likely produced via isomerization. Delta-10 appears in such small amounts that laboratories often misidentify the compound for [cannabichromene] CBC or [cannabicyclol] CBL using standard high-performance liquid chromatography (HPLC) methods.

“You can create any delta you want—delta-8, delta-9, or delta-10—by chemically altering CBD isolate or CBD crude,” David Reckles, president of Private Label Hemp Lab, a hemp testing and manufacturing lab in Florida, told ACS Laboratory. “If you’re using crude CBD, you’ll generally create the reaction through carbon and vitamin C derivatives. If you’re using an isolate, you’ll incorporate solvents and acids.”

RELATED: Understanding Delta-8-THC: Where Does It Come From?

Delta-10 vs. Delta-8 and Delta-9: Chemical Differences

Delta-10 is an isomer of delta-9, Brown says.

Paulson says when one begins to isolate delta-9 or, more commonly, convert THC to CBD, they’ll start to discover the additional isomers (or different classifications of THC).

“Really, all THC isomers chemically have the same basic structure,” he says. “It’s just the placement of one bond that differs between the different isomers.”

For example, as previously reported by Hemp Grower, “delta-8 has a double bond on the 8th carbon chain, and delta-9 has a double bond on the 9th carbon chain.”

Delta-10 follows the same pattern and has a double bond on the 10th carbon chain. And while this seems like a “small distinction, it’s enough to produce slightly different cognitive and physical effects,” Hemp Grower previously reported.

Brown says that a significant difference is delta-8 can essentially only produce one compound, whereas delta-10 can produce up to six different isomers (variations of the same compound).

“What we call delta-10 is really a mixture of two different types of compounds, and then within that, they might have different configurations,” Paulson says. “So, there’s just a lot of different compounds, and that’s one of the reasons why it’s so challenging to quantify accurately. So, in terms of psychoactivity, instead of having to test one compound, you have to test six.” 

Legal Status

According to ACS Laboratory, “Delta-10 THC derived from cannabis is [federally] illegal because marijuana is a schedule 1 controlled substance. However, delta-10 derived from hemp extract exists in a legal gray zone.”

And Brown agrees, arguing that the Agriculture Improvement Act of 2018 (the 2018 Farm Bill) is very “specific to delta-9,” and if a delta-8 or delta-10 product derived from hemp contains less than 0.3% total THC (defined as delta-9 THC plus tetrahydrocannabinolic acid (THCA), its acidic version), then it’s considered “legal.”

The Drug Enforcement Administration’s (DEA) response to the 2018 Farm Bill is: “All synthetically derived tetrahydrocannabinols remain schedule 1 controlled substances.”

“So, in our mind, all tetrahydrocannabinols cannabinoids are considered federally illegal,” Paulson says. “We’re not placing a judgment on that, whether it’s right to do that or not. I just think there hasn’t been a lot of legal challenges to these laws and to that point, people keep on producing delta-8 and delta-10 products….”

More than 12 states have already begun to implement delta-8 bans, while very few states, including New York, Colorado and Alabama, have started to crack down on delta-10.

And Paulson says while delta-10 may currently be “flying under the radar,” he thinks it’s only a “matter of time” before there’s increased regulation.

Filed Under: Cannabis News

  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 26
  • Go to page 27
  • Go to page 28
  • Go to page 29
  • Go to page 30
  • Interim pages omitted …
  • Go to page 94
  • Go to Next Page »

Footer

  • Home
  • Privacy Policy
  • Terms of Service